Tennis elbow treatment showdown ends early
NCT ID NCT02325063
First seen Dec 10, 2025 · Last updated May 06, 2026 · Updated 19 times
Summary
This study aimed to compare three different injections—platelet-rich plasma, botulinum toxin, and steroids—for treating tennis elbow pain. Only 13 people participated before the trial was stopped early. The goal was to see which injection worked best for reducing pain over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENNIS ELBOW are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU de Montpellier - Hôpital Lapeyronie
Montpellier, 34295, France
-
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
Conditions
Explore the condition pages connected to this study.